Features of systemic inflammation in patients with stable COPD

N. Sanina, S. Panina (Dnipropetrovs'k, Ukraine)

Source: International Congress 2014 – COPD: points to ponder
Session: COPD: points to ponder
Session type: Thematic Poster Session
Number: 3631
Disease area: Airway diseases

Congress or journal article abstractE-poster

Abstract

One of the leading mechanisms in COPD pathogenesis is a systemic inflammatory process. Study objective was to assess the characteristics of systemic inflammation in stable COPD patients. The study involved 122 patients with COPD II and III stages, 100 men and 22 women, mean age 53,9 ± 0,9 yrs, disease duration 12,4 ± 0,9 yrs, FEV₁ 40,2 ± 2.8%, smoking index 19,6 ± 2,6 yrs.It was revealed increasing of acute phase substances: C-reactive protein, seromucoid, ceruloplasmin, fibrinogen, g – globulins and lipoxin A4 compared to healthy subjects (p < 0.01), which indicates persistence of systemic inflammation in patients even without COPD exacerbation.Lipoxin A4 level correlated statistically significantly and directly with fibrinogen (r = 0,890), g-globulins (r = 0,840), white blood cells count (r = 0,656), mean corpuscular hemoglobin (the sensitive indicator of hemoglobin synthesis) (r = 0,621), erythrocyte sedimentation rate (r = 0,515), C-reactive protein (r = 0,510), lymphocytes and monocytes count (r = 0,451 and r = 0,439), total cholesterol level (r = 0,400) and HDL-cholesterol (r = 0,390). All correlations were significant with p<0,01.Thus, in patients with COPD even without exacerbation observes high level of inflammatory mediators production, activation of lymphocyte cytokine pool, disruption of normal metabolism of arachidonic acid. Therefore, in patients proceeds an active chronic systemic inflammation process, involving cell and plasma active phase indicators with homeostatic imbalance, so, therapy that reduces the intensity of systemic inflammation is a priority even in stable COPD.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Sanina, S. Panina (Dnipropetrovs'k, Ukraine). Features of systemic inflammation in patients with stable COPD. Eur Respir J 2014; 44: Suppl. 58, 3631

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Endothelial dysfunction and systemic inflammation in different COPD phenotypes
Source: International Congress 2014 – COPD physiopathology
Year: 2014

The systemic inflammation and factors of coagulation in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – COPD markers
Year: 2014


Biomarkers in COPD exacerbation, the role of adiponectin
Source: International Congress 2014 – Predictors
Year: 2014

COPD, an inflammatory systemic disease. Inflammatory parameters in a group of COPD patients
Source: International Congress 2014 – Lung function, COPD and inflammation
Year: 2014

Role of inflammatory biomarkers in COPD
Source: International Congress 2016 – Systemic biomarkers
Year: 2016


The role of COPD in development of osteoporosis
Source: International Congress 2014 – Markers
Year: 2014


Exacerbations in patients with chronic obstructive lung disease (COPD) and concomitant asthma
Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease?
Year: 2014


Autoreactivity and inflammatory phenotypes in patients with COPD and bronchial asthma
Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Year: 2016

Role of activated complement in COPD exacerbation recovery
Source: International Congress 2014 – Comorbidities
Year: 2014


Mukoregulatory drugs in treating COPD
Source: International Congress 2014 – Predictors
Year: 2014


Neutrophil CD 64 expression as a diagnostic marker of pneumonia in patients with acute COPD exacerbation
Source: International Congress 2014 – Markers
Year: 2014

Metabolic syndrome in patients with COPD
Source: International Congress 2014 – Clinical presentations
Year: 2014

Metabolic syndrome in patients with COPD and their association with systemic inflammation
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015


Characteristics of essential hypertension in COPD patients
Source: International Congress 2014 – COPD: points to ponder
Year: 2014


Analysis of the microbiota of sputum samples from patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – COPD exacerbations
Year: 2014


Increased heart rate modulation, sympathetic dominance and systemic inflammation in chronic obstructive pulmonary disease
Source: International Congress 2014 – Markers
Year: 2014

Nutritional status in chronic obstructive pulmonary disease
Source: International Congress 2014 – Comorbidities
Year: 2014


Gender differences in COPD patients
Source: International Congress 2014 – Clinical presentations
Year: 2014

The distribution of phenotypes in a population of severe COPD
Source: International Congress 2014 – COPD exacerbations
Year: 2014



Inflammatory markers and COPD phenotypes as predictors of COPD exacerbations
Source: Annual Congress 2013 –Investigating COPD in longitudinal studies
Year: 2013